4A3.PBAD-repL(WT).J23115-gfp
(Plasmid
#197872)
-
PurposeArabinose induced expression of wildtype repL gene, which triggers DNA replication in cis and in trans, weak level of constitutive GFP expression
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 197872 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepSC101 (4A3)
- Backbone size w/o insert (bp) 3197
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert 1
-
Gene/Insert namepart kilA/repL
-
SpeciesBacteriophage P1 (E. coli P1 lysogen EMG16)
-
Insert Size (bp)899
-
Mutationcontains only the 24 bp of 3'-end of kilA gene sequence
- Promoter PBAD
Cloning Information for Gene/Insert 1
- Cloning method Gibson Cloning
- 5′ sequencing primer cataagattagcggatcctac
- 3′ sequencing primer gatgacgtggcaataaagaataag (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namegfp
-
Insert Size (bp)717
- Promoter Bba_J23115
Cloning Information for Gene/Insert 2
- Cloning method Gibson Cloning
- 5′ sequencing primer CTAGAgctagcattgtaccaagg
- 3′ sequencing primer CATGGAACAGGTAGTTTTCCAG (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
4A3.PBAD-repL(WT).J23115-gfp was a gift from Baojun Wang (Addgene plasmid # 197872 ; http://n2t.net/addgene:197872 ; RRID:Addgene_197872) -
For your References section:
An adenine/thymidine-rich region is integral to RepL-mediated DNA replication. Huan YW, Brown R, Wang B. Front Microbiol. 2023 Feb 9;14:1095671. doi: 10.3389/fmicb.2023.1095671. eCollection 2023. 10.3389/fmicb.2023.1095671 PubMed 36846746